KDR2-2 Suspension Eyedrop

KDR2-2 · Sun Yat-sen University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KDR2-2 Suspension Eyedrop, covering 2024-12-11 to 2024-12-11. Get the full timeline:

Most recent: Clinical Trial Update: KDR2-2 Suspension Eyedrop in the Treatment of Neovascular Glaucoma (KDR-NVG) Trial [Phase 1]